Beyond Air, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)
Beyond Air, Inc. (XAIR) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) of $23.14 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Notes
us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease · last filed 2017-03-31
- Beyond Air, Inc. sec schedule, 12-09, valuation allowances and reserves, period increase (decrease) for fiscal 2016 was $23.14K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) 12 month |
|---|---|
| 2016-12-31 | $23.14K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |